Breast cancer treatment: When less is more
PLOS Medicine · 26.10.2026 · 23 (10) · e1005284
DOI: 10.1371/journal.pmed.1005284 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift PLOS Medicine, online erschienen am 26.10.2026. Verfasst von Katarzyna Starowicz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Public Library of Science, Cambridge, United Kingdom. Hauptthemen laut MEDLINE: Breast Neoplasms, Overtreatment, Antineoplastic Agents. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Breast cancer treatment using systemic therapies has often focussed on remission and survival, but can cause severe side effects that negatively impact patient quality of life and function, sometimes with limited clinical benefit. In the era of precision oncology, one of the greatest opportunities may not be in identifying more patients for treatment, but rather in identifying those who can safely receive less to avoid overtreatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Public Library of Science, Cambridge, United Kingdom.
ORCID-Profile: Katarzyna Starowicz
Zitieren
APA
Starowicz, K., & PLOS Medicine Staff Editors (2026). Breast cancer treatment: When less is more. PLOS Medicine, 23(10), e1005284. https://doi.org/10.1371/journal.pmed.1005284
Vancouver
Starowicz K, PLOS Medicine Staff Editors. Breast cancer treatment: When less is more. PLOS Medicine. 2026;23(10):e1005284. doi:10.1371/journal.pmed.1005284
BibTeX
@article{Starowicz2026,
author = {Starowicz, Katarzyna and PLOS Medicine Staff Editors, PLOS Medicine Staff Editors},
title = {Breast cancer treatment: When less is more},
journal = {PLOS Medicine},
year = {2026},
volume = {23},
number = {10},
pages = {e1005284},
doi = {10.1371/journal.pmed.1005284}
}
EUVIMED